The chemical class known as SUSP4 Activators encompasses various compounds that influence cellular processes and pathways which can lead to the activation of the SUMO-specific protease 4 (SUSP4). These activators operate through diverse mechanisms to affect the SUMOylation and deSUMOylation balance within cells. By targeting different aspects of the cellular machinery, these molecules can increase the activity of SUSP4. Some activators can exert their effects by inhibiting enzymes that are responsible for the addition of SUMO (Small Ubiquitin-like Modifier) groups to proteins, while others can modulate the proteasome system, which is crucial for protein degradation. Additionally, certain activators can alter lysosomal function, thereby impacting the turnover of proteins, including those that are SUMOylated.
Furthermore, activators within this class can also modulate various signaling pathways, such as those controlled by GSK-3β, PI3K/Akt/mTOR, which have downstream consequences on nuclear transport and protein synthesis. These effects, in turn, can lead to the activation of SUSP4. Some compounds within this class target histone acetyltransferases or sirtuins, thereby influencing transcriptional regulation that can lead to the activation of SUSP4. Collectively, the actions of these chemicals can lead to an increased presence of deSUMOylated proteins in the cell, which is indicative of heightened SUSP4 activity. The range of mechanisms these activators employ underscores the complexity of the cellular environment and the intricate interplay of pathways that converge to regulate protein function and activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
Anacardic acid inhibits histone acetyltransferase, which could possibly activate SUSP4 by affecting transcription and SUMOylation-related transcriptional regulation. | ||||||
(−)Epicatechin | 490-46-0 | sc-205672 sc-205672A | 1 mg 5 mg | $51.00 $138.00 | ||
Ginkgolic acid is known to inhibit SUMO-activating enzyme E1 and could possibly activate SUSP4 by affecting the overall SUMOylation process. | ||||||
Tenovin-6 | 1011557-82-6 | sc-224296 sc-224296A | 1 mg 5 mg | $272.00 $1214.00 | 9 | |
Tenovin-6 acts as a SIRT1 and SIRT2 inhibitor, which could possibly activate SUSP4 by impacting deacetylation processes. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, which could possibly activate SUSP4 by having a broad impact on cellular processes including SUMOylation. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 inhibits the proteasome, which could possibly activate SUSP4 by increasing the levels of SUMOylated proteins. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride affects GSK-3β signaling and could possibly activate SUSP4 by having downstream effects on nuclear transport and SUMOylation processes. | ||||||
PI-103 | 371935-74-9 | sc-203193 sc-203193A | 1 mg 5 mg | $33.00 $131.00 | 3 | |
PI-103 is a PI3K/Akt/mTOR pathway inhibitor, which could possibly activate SUSP4 by altering cellular processes including SUMOylation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that could possibly activate SUSP4 by altering cellular processes, thereby potentially influencing the SUMOylation landscape. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR pathway, which could possibly activate SUSP4 by having a broad range of effects on cell growth and protein synthesis. | ||||||